Clinical determination of the natural distensibility of the human ureter: initial study

Sohrab N. Ali,Amanda McCormac,Andrei D. Cumpanas,Jaime Altamirano‐Villarroel,Paul Piedras,Minh‐Chau Vu,Andrew S. Afyouni,Zachary E. Tano,Kathryn Osann,Michael Klopfer,Pengbo Jiang,Roshan M. Patel,Jaime Landman,Ralph V. Clayman

DOI: https://doi.org/10.1111/bju.16564

2024-10-28

BJU International

Abstract:Objectives To define the natural distensibility of the human ureter and evaluate the impact of other possibly favourable factors on ureteric distensibility. Patients and Methods A total of 101 patients undergoing ureteroscopic stone removal or percutaneous nephrolithotomy underwent ureteric sizing using sequential passage of 37‐cm urethral dilators in 2‐F increments while attached to a unique force sensor. Insertion forces were limited to 6 N. After 6 N was attained, an appropriately sized ureteric access sheath was passed. At the conclusion of each procedure, Post‐Ureteroscopic Lesion Scale score was determined. Results Urethral dilators were passed in 61% of patients at ≤14 F; 39% of patients accepted urethral dilators of ≥16 F. The mean dilator size was 14 F. Multivariate logistic regression analysis revealed that preprocedural ureteric stenting and antibiotic use favoured passage of 16‐F dilators (odds ratio [OR] 5.16, 95% confidence interval [CI] 1.70–15.62 [P = 0.004] and OR 5.15, 95% CI 1.743–15.243 [P = 0.003], respectively). Neither tamsulosin nor prior urinary tract infection had an impact on ureteric size (OR 0.765, 95% CI 0.281–2.084 [P = 0.601], OR 1.049, 95% CI 0.269–4.089 [P = 0.945], respectively). Conclusion Using continuous insertion force monitoring and a 6‐N threshold, the majority of unstented adult human ureters within our patient population safely accommodated a 14‐F dilator. Safe passage of a 16‐F dilator at the 6‐N threshold was more likely among patients with a preexisting indwelling ureteric stent or patients who were treated with antibiotics within a week of the procedure.

urology & nephrology